Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H14N4O5S |
Molecular Weight | 398.393 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=C(O)C=CC(=C1)\N=N\C2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
InChI
InChIKey=NCEXYHBECQHGNR-QZQOTICOSA-N
InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+
Molecular Formula | C18H14N4O5S |
Molecular Weight | 398.393 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:46:47 UTC 2023
by
admin
on
Fri Dec 15 15:46:47 UTC 2023
|
Record UNII |
3XC8GUZ6CB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000005760
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
NDF-RT |
N0000005760
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
WHO-VATC |
QA07EC01
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
LIVERTOX |
NBK548792
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
NDF-RT |
N0000005760
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
NDF-RT |
N0000175781
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
2.4
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
WHO-ATC |
A07EC01
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
17.3
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
||
|
NDF-RT |
N0000005760
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D012460
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
DTXSID0021256
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
3XC8GUZ6CB
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
C29469
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
2210
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
599-79-1
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
2525
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
3XC8GUZ6CB
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
203730
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
1636005
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
SUB20720
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
9524
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | RxNorm | ||
|
667219
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
SUB10727MIG
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
100000091572
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
SULFASALAZINE
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | Description: A bright yellow to brownish yellow powder; odourless. Solubility: Practically insoluble in water and ether R; very slightly soluble in ethanol (~750 g/l) TS; soluble in alkali hydroxides. Category: Antibacterial drug. Storage: Sulfasalazine should be kept in a tightly closed container, protected from light. Additional information: Sulfasalazine melts at about 255?C with decomposition. Definition: Sulfasalazine contains not less than 93.0% and not more than 103.0% of C18H14N4O5S, calculated with reference to the dried substance. | ||
|
DB00795
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
3395
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
209-974-3
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
m10343
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL421
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
4840
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
Sulfasalazine
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
9334
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY | |||
|
Sulfasalazine
Created by
admin on Fri Dec 15 15:46:48 UTC 2023 , Edited by admin on Fri Dec 15 15:46:48 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
Prevents translocation into nuclease
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
TRANSPORTER -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
Inhibite the Hb-catalyzed peroxidative reaction
|
||
|
METABOLITE INACTIVE -> PARENT |
Not inhibite the Hb-catalyzed peroxidative reaction
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
Inhibite the Hb-catalyzed peroxidative reaction
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||